HARVARD BIOSCIENCE, INC. (HBIO) Shareholders’ equity 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) shareholders’ equity at each fiscal year-end, per SEC filings.
$13.7MFY2025 · since FY2016: $72.2M → $13.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.7M | -78.3% |
| FY2024 | $63.3M | -13.3% |
| FY2023 | $73.1M | +1.2% |
| FY2022 | $72.2M | -13.4% |
| FY2021 | $83.4M | +8.8% |
| FY2020 | $76.7M | -6.1% |
| FY2019 | $81.7M | -1.2% |
| FY2018 | $82.7M | +2.3% |
| FY2017 | $80.9M | +12.1% |
| FY2016 | $72.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice